CORCEPT THERAPEUTICS INC (CORT)

SEC filing

CORCEPT THERAPEUTICS INC

CORT · CIK 1088856

4 · Sep 3, 2026 · President, Oncology Vieira Roberto Wandenkolk sold 58.33K shares at $110.76/share ($6.5M); exercised options for 116.67K shares; was granted 276 shares at $56.69/share ($15,646); reported 102 shares

President, Oncology Vieira Roberto Wandenkolk sold 58.33K shares at $110.76/share ($6.5M); exercised options for 116.67K shares; was granted 276 shares at $56.69/share ($15,646); reported 102 shares

Filed: Sep 3, 2026
Period: Sep 1, 2026
Accession: 0001193125-26-382456
Filer: CORCEPT THERAPEUTICS INC

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov